Literature DB >> 30521375

Low-value care: antipsychotic medication use among community-dwelling medicare beneficiaries with Alzheimer's disease and related dementias and without severe mental illness.

Mona Nili1, Chan Shen2, Usha Sambamoorthi1.   

Abstract

Background: Antipsychotic medication use among elderly with Alzheimer's disease and related dementias (ADRD) and without severe mental illness is considered as low-value care. Our objective was to assess the factors associated with this inappropriate use of antipsychotic medications among community-dwelling Medicare beneficiaries with ADRD and without severe mental illness.
Methods: This study used a retrospective cross-sectional design. Data for this study were derived from the nationally representative Medicare Current Beneficiary Survey (MCBS) and linked Medicare claims. Logistic regression models were used to examine factors associated with low-value care.
Results: Overall 8.5% had low-value care. In the final adjusted logistic regression model, race other than Hispanic or Non-Hispanic White (AOR =0.54, 95% CI = [0.30,0.98]), individuals over 80 years of age (AOR =0.53, 95% CI = [0.36,0.76]), and obese individuals (AOR =0.55, 95% CI = [0.35,0.85]) had significantly lower odds of receiving low-value care. Those with depression (AOR =1.71, 95% CI = [1.21, 2.43]), who lived in the Midwest (AOR =1.7, 95% CI = [1.08,2.68]), and with a higher number of ADL limitations (AOR =1.28, 95% CI = [1.19,1.38]) had significantly higher odds of low-value care.Conclusions: There were subgroup differences in low-value care. Interventions may target these subgroups to reduce low-value care.

Entities:  

Keywords:  Low-value care; Alzheimer’s disease and related dementias; Antipsychotic medications; Medicare beneficiaries; severe mental illness

Mesh:

Substances:

Year:  2018        PMID: 30521375      PMCID: PMC6551311          DOI: 10.1080/13607863.2018.1544211

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  22 in total

1.  Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia.

Authors:  YongJoo Rhee; John G Csernansky; Linda L Emanuel; Chang-Gok Chang; Joseph W Shega
Journal:  J Am Geriatr Soc       Date:  2011-09-23       Impact factor: 5.562

2.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

3.  Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care.

Authors:  Hugo Lövheim; Per-Olof Sandman; Kristina Kallin; Stig Karlsson; Yngve Gustafson
Journal:  Int Psychogeriatr       Date:  2006-07-31       Impact factor: 3.878

4.  Difficulties encountered by general practitioners during acute behavioral disturbances of their dementia patients.

Authors:  Marion Campana; Sylvie Bonin-Guillaume; Ramzi Yagoubi; Julie Berbis; Caroline Franqui
Journal:  Geriatr Psychol Neuropsychiatr Vieil       Date:  2016-06-01

5.  COVARIATE DECOMPOSITION METHODS FOR LONGITUDINAL MISSING-AT-RANDOM DATA AND PREDICTORS ASSOCIATED WITH SUBJECT-SPECIFIC EFFECTS.

Authors:  John M Neuhaus; Charles E McCulloch
Journal:  Aust N Z J Stat       Date:  2014-12       Impact factor: 0.640

6.  Choosing wisely: prevalence and correlates of low-value health care services in the United States.

Authors:  Carrie H Colla; Nancy E Morden; Thomas D Sequist; William L Schpero; Meredith B Rosenthal
Journal:  J Gen Intern Med       Date:  2014-11-06       Impact factor: 5.128

7.  Pharmacotherapeutic management of dementia across settings of care.

Authors:  Gail B Rattinger; Mehmet Burcu; Sarah K Dutcher; Pankdeep T Chhabra; Paul B Rosenberg; Linda Simoni-Wastila; Christine S Franey; Loreen D Walker; Ilene H Zuckerman
Journal:  J Am Geriatr Soc       Date:  2013-04-16       Impact factor: 5.562

8.  Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial.

Authors:  Kenneth Wells; Cathy Sherbourne; Michael Schoenbaum; Susan Ettner; Naihua Duan; Jeanne Miranda; Jürgen Unützer; Lisa Rubenstein
Journal:  Arch Gen Psychiatry       Date:  2004-04

9.  Matching MCBS (Medicare Current Beneficiary Survey) and Medicare data: the best of both worlds.

Authors:  F J Eppig; G S Chulis
Journal:  Health Care Financ Rev       Date:  1997

10.  A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents.

Authors:  Andrea Foebel; Anna Ballokova; Nathalie I H Wellens; Daniela Fialova; Koen Milisen; Rosa Liperoti; John P Hirdes
Journal:  BMC Geriatr       Date:  2015-10-19       Impact factor: 3.921

View more
  2 in total

1.  Associations Between Low-Value Medication in Dementia and Healthcare Costs.

Authors:  Moritz Platen; Steffen Flessa; Anika Rädke; Diana Wucherer; Jochen René Thyrian; Annelie Scharf; Wiebke Mohr; Franka Mühlichen; Wolfgang Hoffmann; Bernhard Michalowsky
Journal:  Clin Drug Investig       Date:  2022-04-28       Impact factor: 3.580

2.  Prevalence of Low-Value Care and Its Associations with Patient-Centered Outcomes in Dementia.

Authors:  Moritz Platen; Steffen Fleßa; Anika Rädke; Diana Wucherer; Jochen René Thyrian; Wiebke Mohr; Annelie Scharf; Franka Mühlichen; Wolfgang Hoffmann; Bernhard Michalowsky
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.